摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

((2R,3S,5S,6S)-6-(3-(benzyloxy)-5-bromophenyl)-3-methoxy-5-methyltetrahydro-2H-pyran-2-yl)methanol | 1225609-11-9

中文名称
——
中文别名
——
英文名称
((2R,3S,5S,6S)-6-(3-(benzyloxy)-5-bromophenyl)-3-methoxy-5-methyltetrahydro-2H-pyran-2-yl)methanol
英文别名
[(2R,3S,5S,6S)-6-(3-bromo-5-phenylmethoxyphenyl)-3-methoxy-5-methyloxan-2-yl]methanol
((2R,3S,5S,6S)-6-(3-(benzyloxy)-5-bromophenyl)-3-methoxy-5-methyltetrahydro-2H-pyran-2-yl)methanol化学式
CAS
1225609-11-9
化学式
C21H25BrO4
mdl
——
分子量
421.331
InChiKey
FKWLGVJODSWPBY-VJICWTENSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    47.9
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ((2R,3S,5S,6S)-6-(3-(benzyloxy)-5-bromophenyl)-3-methoxy-5-methyltetrahydro-2H-pyran-2-yl)methanol 在 aluminum (III) chloride 、 苯甲醚盐酸 作用下, 以 二氯甲烷 为溶剂, 以94%的产率得到
    参考文献:
    名称:
    Synthesis of Reblastatin, Autolytimycin, and Non-Benzoquinone Analogues: Potent Inhibitors of Heat Shock Protein 90
    摘要:
    A full account of an asymmetric synthesis of reblastatin (1) and the first total synthesis of autolytimycin (2) and related structural compounds is described. The syntheses expand the utility of a highly regio- and diastereoselective hydrometalation aldehyde addition sequence to assemble the fully functionalized ansa chain of the natural products. Also documented is an intramolecular copper-mediated amidation reaction to close the 19-membered macrolactams. The amidation reaction was also employed for the generation of structural derivatives (6-9) of phenolic ansamycins. Ansamycin natural products and selected structural analogues were evaluated in a competitive binding assay to breast cancer cell lysate and a cytotoxicity assay. Both reblastatin (1) and autolytimycin (2) were shown to bind the heat shock protein 90 with enhanced binding activity (similar to 25 nM) than 17-allylamino-17-demethoxygeldanamycin (17-AAG, 4), a geldanamycin (3) derivative currently under evaluation for treatment of cancer (similar to 100 nM).
    DOI:
    10.1021/jo1000109
  • 作为产物:
    描述:
    (2S,3S,5S,6S)-methyl 6-(3-(benzyloxy)-5-bromophenyl)-3-methoxy-5-methyltetrahydro-2H-pyran-2-carboxylate锂硼氢 作用下, 以 乙醚 为溶剂, 反应 1.5h, 以89%的产率得到((2R,3S,5S,6S)-6-(3-(benzyloxy)-5-bromophenyl)-3-methoxy-5-methyltetrahydro-2H-pyran-2-yl)methanol
    参考文献:
    名称:
    Synthesis of Reblastatin, Autolytimycin, and Non-Benzoquinone Analogues: Potent Inhibitors of Heat Shock Protein 90
    摘要:
    A full account of an asymmetric synthesis of reblastatin (1) and the first total synthesis of autolytimycin (2) and related structural compounds is described. The syntheses expand the utility of a highly regio- and diastereoselective hydrometalation aldehyde addition sequence to assemble the fully functionalized ansa chain of the natural products. Also documented is an intramolecular copper-mediated amidation reaction to close the 19-membered macrolactams. The amidation reaction was also employed for the generation of structural derivatives (6-9) of phenolic ansamycins. Ansamycin natural products and selected structural analogues were evaluated in a competitive binding assay to breast cancer cell lysate and a cytotoxicity assay. Both reblastatin (1) and autolytimycin (2) were shown to bind the heat shock protein 90 with enhanced binding activity (similar to 25 nM) than 17-allylamino-17-demethoxygeldanamycin (17-AAG, 4), a geldanamycin (3) derivative currently under evaluation for treatment of cancer (similar to 100 nM).
    DOI:
    10.1021/jo1000109
点击查看最新优质反应信息

文献信息

  • Synthesis of Reblastatin, Autolytimycin, and Non-Benzoquinone Analogues: Potent Inhibitors of Heat Shock Protein 90
    作者:Iwona E. Wrona、Alexander Gozman、Tony Taldone、Gabriela Chiosis、James S. Panek
    DOI:10.1021/jo1000109
    日期:2010.5.7
    A full account of an asymmetric synthesis of reblastatin (1) and the first total synthesis of autolytimycin (2) and related structural compounds is described. The syntheses expand the utility of a highly regio- and diastereoselective hydrometalation aldehyde addition sequence to assemble the fully functionalized ansa chain of the natural products. Also documented is an intramolecular copper-mediated amidation reaction to close the 19-membered macrolactams. The amidation reaction was also employed for the generation of structural derivatives (6-9) of phenolic ansamycins. Ansamycin natural products and selected structural analogues were evaluated in a competitive binding assay to breast cancer cell lysate and a cytotoxicity assay. Both reblastatin (1) and autolytimycin (2) were shown to bind the heat shock protein 90 with enhanced binding activity (similar to 25 nM) than 17-allylamino-17-demethoxygeldanamycin (17-AAG, 4), a geldanamycin (3) derivative currently under evaluation for treatment of cancer (similar to 100 nM).
查看更多